Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ATM serine/threonine kinase | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0026 | 0.0089 | 0.0605 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.0001 | 0.0006 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0429 | 0.9182 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0087 | 0.1474 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0036 | 0.0326 | 1 |
Entamoeba histolytica | hypothetical protein | 0.003 | 0.0184 | 0.563 |
Entamoeba histolytica | SWIRM domain protein | 0.0036 | 0.0326 | 1 |
Echinococcus multilocularis | serine protein kinase ATM | 0.003 | 0.0184 | 0.02 |
Toxoplasma gondii | FATC domain-containing protein | 0.003 | 0.0184 | 0.1247 |
Onchocerca volvulus | 0.0466 | 1 | 0.5 | |
Echinococcus granulosus | serine protein kinase ATM | 0.003 | 0.0184 | 0.02 |
Mycobacterium ulcerans | monoamine oxidase | 0.0087 | 0.1474 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0466 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.0326 | 1 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0087 | 0.1474 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0087 | 0.1474 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0326 | 0.0326 |
Schistosoma mansoni | amine oxidase | 0.0087 | 0.1474 | 0.1605 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.2292 | 0.2292 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.003 | 0.0184 | 0.1247 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0087 | 0.1474 | 1 |
Mycobacterium ulcerans | dehydrogenase | 0.0087 | 0.1474 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.003 | 0.0184 | 0.563 |
Brugia malayi | SWIRM domain containing protein | 0.0036 | 0.0326 | 0.0326 |
Loa Loa (eye worm) | hypothetical protein | 0.0429 | 0.9182 | 0.9182 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0087 | 0.1474 | 0.1605 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.1474 | 0.1474 |
Loa Loa (eye worm) | hypothetical protein | 0.0429 | 0.9182 | 0.9182 |
Echinococcus multilocularis | 0.0087 | 0.1474 | 0.1605 | |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.003 | 0.0184 | 0.02 |
Echinococcus multilocularis | SWI:SNF complex subunit SMARCC2 | 0.0036 | 0.0326 | 0.0355 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0087 | 0.1474 | 0.5 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0087 | 0.1474 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0087 | 0.1474 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0087 | 0.1474 | 0.5 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.003 | 0.0184 | 0.0184 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0087 | 0.1474 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0087 | 0.1474 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0087 | 0.1474 | 1 |
Schistosoma mansoni | SWI/SNF complex-related | 0.0036 | 0.0326 | 0.0355 |
Leishmania major | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.0001 | 0.0006 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0087 | 0.1474 | 0.5 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0429 | 0.9182 | 1 |
Schistosoma mansoni | amine oxidase | 0.0087 | 0.1474 | 0.1605 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0087 | 0.1474 | 1 |
Brugia malayi | hypothetical protein | 0.0087 | 0.1474 | 0.1474 |
Toxoplasma gondii | SWIRM domain-containing protein | 0.0036 | 0.0326 | 0.2215 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0087 | 0.1474 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0087 | 0.1474 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.1474 | 0.1474 |
Echinococcus granulosus | SWI:SNF complex subunit SMARCC2 | 0.0036 | 0.0326 | 0.0355 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0087 | 0.1474 | 0.1605 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0124 | 0.2292 | 0.2292 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0087 | 0.1474 | 0.5 |
Entamoeba histolytica | SWIRM domain protein | 0.0036 | 0.0326 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0036 | 0.0326 | 1 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0087 | 0.1474 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0087 | 0.1474 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0087 | 0.1474 | 0.5 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.003 | 0.0184 | 1 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0087 | 0.1474 | 0.1605 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0429 | 0.9182 | 1 |
Giardia lamblia | hypothetical protein | 0.0036 | 0.0326 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0089 | 0.0089 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0087 | 0.1474 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 2.5119 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.